Resources
Nanopharm Resources
As a leader in the field of developing and testing nasal and inhaled drug delivery products, Nanopharm is committed to advancing scientific knowledge in this specialized area. Our team of dedicated scientists conduct cutting-edge research, and we are excited to share our content with you. By sharing our scientific publications webinars and white papers, we aim to foster a spirit of collaboration, inspire new ideas, and contribute to the collective knowledge of the OINDP scientific community. We encourage you to explore our resources page but please visit this section at regular intervals as our team continues to share the latest scientific articles with you.
11 February 2025
Advancing Alternative Bioequivalence for OINDPs
Bioequivalence, Nanopharm, OINDPs
Filter Resources By
10 Oct 2024
Analytical Services, Inhalation, Nanopharm
06 Oct 2024
Inhalation, Innovation & Insights, Nasal Sprays
01 Dec 2022
Drug Product, Generic, Inhalation, OINDP, Pharmaceutical regulatory
11 May 2022
Biologics, COVID-19, Nasal, Nasal Delivery, therapeutics
01 Apr 2022
Aptar Pharma, drug delivery, Nasal
03 Nov 2021
Aerodynamic, Antigen, Dry Powder, GLA, Human Papillomavirus, Inhalation, Nanopharm, Performance, Vaccine
11 Jan 2021
drug delivery, Inhalation, Low GWP, Nanopharm, pMDIs, Propellants, Valve and Actuator
01 Jan 2021
DPI, drug delivery, Dry powder inhaler, Inhalation, Particle Size, respiratory diseases
02 Jan 2020
DPI, Drug Development, Dry powder inhaler, Fluticasone Propionate, Inhalation
01 Feb 2018
bioequivalence, Drug Development, Formulation, Generic, Nasal, OINDP
